Table 1.
Baseline characteristics of patients undergoing SR or PS
| Characteristics | SR (n = 75) | PS (n = 14) | p |
|---|---|---|---|
| Age (years) | 44.0 ± 10.0 | 42.6 ± 8.3 | 0.635 |
| Sex (male/female) | 22 (29.3%)/53(70.7%) | 8 (57.1%)/6 (42.9%) | 0.087 |
| BMI | 22.4 ± 2.8 | 21.7 ± 2.8 | 0.395 |
| Number of hemangiomas (solitary/multiple) | 34 (45.3%)/41(54.7%) | 7 (50%)/7 (50%) | 0.748 |
| Hemangioma size (mm) | 90.0 (172.0–49.0) | 76.0 (152–60) | 0.127 |
| Location of hemangioma | 0.839 | ||
| Non-risk areas | 65 (86.7%) | 13 (92.9%) | |
| Risk areasa | 10 (13.3%) | 1 (7.1%) | |
| ALT (U/L) | 21.0 (59.0–9.0) | 20.5 (41.0–10.0) | 0.946 |
| AST (U/L) | 24.4 ± 7.7 | 20.5 ± 5.4 | 0.076 |
| TB (umol/L) | 11.8 (39.0–2.5) | 11.1 (20.6–6.0) | 0.844 |
| Alb (g/L) | 40.8 ± 4.1 | 40.4 ± 3.8 | 0.726 |
| WBC (× 109/L) | 5.7 (13.0–2.8) | 5.6 (8.7–4.1) | 0.857 |
| PT (s) | 12.1 (15.7–10.1) | 11.6 (13.8–10.3) | 0.108 |
| Hb (g/L) | 125.1 ± 20.6 | 127.0 ± 22.3 | 0.753 |
| Plt (109/L) | 235.9 ± 65.1 | 221.0 ± 39.9 | 0.413 |
| SCr (umol/L) | 66.4 (147.0–48.0) | 72.0 (107.0–54.0) | 0.094 |
Data are shown as mean ± SD or mean (range)
aHemangiomas in risk areas refer to those located within 5 mm of the diaphragmatic dome, large vessels, or cavity viscera